However, the fact that cholestasis induced by an LPS-induced inflammatory response can only be attenuated by the combined administration of antagonistic antibodies against both TNF-α as well as IL-1β suggests that IL-1β has a relevant role in this context. The gene discussed is IL1B; the disease is cholestasis.